Recruiting
Phase 2

Radiotherapy with ctDNA

Sponsor:

Ohio State University Comprehensive Cancer Center

Code:

NCT06323460

Conditions

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8

Oropharyngeal Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

External Beam Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2025-02-14.